A Study to Assess the Concentrations of Risankizumab in the Breast Milk of Adult Lactating Women With Inflammatory Bowel Disease

Clinical trial NCT06346288 · COMPLETED

Trial details

NCT number: NCT06346288
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Inflammatory Bowel Disease

Start date: 2024-04-24
Primary completion: 2026-02-05
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.